Physician

Alan D Strumeyer, M.D.

According to 2025 Medicare claims, Alan Strumeyer, M.D. (NPI: 1952325821) practices urology in the Newark, NJ market, with the plurality of this provider's patient population coming from Morris, NJ. This provider's primary affiliated billing organization is SUMMIT MEDICAL GROUP PA (NPI: 1942254347; TIN: 223487984) and primary practice location at 07834-2901. Strumeyer is affiliated with the Summit Health ACO (ACO ID: A5049), participating under the MSSP model.

Strumeyer's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 768 traditional Medicare patients, billed 31,764 HCPCS/CPT codes, and received $447,562 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,708 prescription claims across 723 beneficiaries totaling $395,950 in drug costs, led by Myrbetriq (Mirabegron). DME data shows 49 claims. Open Payments data shows 24 records totaling $1,783. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $227,934 to $447,562. Similarly, Part D prescription costs have moved sharply higher in recent years, from $110,632 to $395,950. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $716 and ending at $1,128.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	837	20,270	$227,934
2016	779	21,195	$197,081
2017	710	16,773	$251,981
2018	686	19,926	$270,751
2019	663	31,538	$276,841
2020	613	27,765	$248,635
2021	687	32,165	$323,442
2022	718	30,249	$336,613
2023	708	31,449	$340,520
2024	768	31,764	$447,562

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	250	1,059	$110,632
2016	246	1,093	$116,977
2017	306	1,233	$149,653
2018	318	1,304	$155,692
2019	351	1,404	$151,659
2020	453	1,777	$260,603
2021	477	1,870	$329,376
2022	652	2,529	$1,113,247
2023	682	2,661	$582,011
2024	723	2,708	$395,950

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	30	$2,052
2016	N/R	40	$799
2017	N/R	57	$8,039
2018	N/R	71	$10,631
2019	N/R	64	$13,295
2020	N/R	96	$20,032
2021	N/R	11	$325
2022	N/R	16	$2,026
2023	N/R	30	$2,575
2024	N/R	49	$6,451

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	356	513	$100
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	478	783	$70
51798	Ultrasound measurement of bladder capacity after voiding	251	365	$9
36415	Insertion of needle into vein for collection of blood sample	217	288	$9
81003	Automated urinalysis test	414	700	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Myrbetriq	Mirabegron	133	7,050	$102,988
Gemtesa	Vibegron	131	6,497	$102,289
Xyosted	Testosterone Enanthate	31	1,092	$22,614
Tamsulosin Hcl	Tamsulosin Hcl	670	53,712	$11,040
Tolterodine Tartrate Er	Tolterodine Tartrate	81	3,930	$6,301

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	49	$6,451

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	24	$1,783	Axonics, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alan D. Strumeyer, M.D.?

Tedicare shows public-source Medicare data for Alan D. Strumeyer, M.D. (NPI 1952325821), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alan D. Strumeyer, M.D. have ACO affiliation data?

Alan D. Strumeyer, M.D. is shown with ACO affiliation data for Summit Health ACO (MSSP, ACO ID A5049).

What billing organization is linked to Alan D. Strumeyer, M.D.?

Alan D. Strumeyer, M.D. is linked to SUMMIT MEDICAL GROUP PA (billing NPI 1942254347) in the available physician profile data.

Does Alan D. Strumeyer, M.D. have Open Payments data?

Alan D. Strumeyer, M.D. has 24 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.